Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
Clinical trial data suggests tirzepatide produces greater average weight loss than semaglutide, largely because it activates both the GLP-1 and GIP receptors rather than just GLP-1
intact skin blocks molecules above 500
Research on incisional wounds shows BPC-157 increases tensile strength and improves collagen organization in healing surgical sites
Plant Physiol 141(4):16531665
Eli Lilly Trial Finder: Visit trials.lilly.com for a more patient-friendly interface
US$ 29.42
US$ 22.22
US$ 27.87
US$ 27.19
US$ 23.63
US$ 20.26
US$ 28.27
US$ 23.70
US$ 21.91
US$ 25.33
